Jeffrey Moore

824 citations
8 papers · 347 indexed · h-index 7
Topics
Gallbladder and Bile Duct Disorders (4 papers)Pediatric Hepatobiliary Diseases and Treatments (4 papers)Coronary Artery Anomalies (2 papers)
Partner nations
United StatesCanada

In The Last Decade

Jeffrey Moore

8 papers receiving 345 citations

Peers

Jeffrey Moore
Comparison fields: 5 of 46
  • Surgery 287
  • Pulmonary and Respiratory Medicine 202
  • Oncology 30
  • Immunology 26
  • Molecular Biology 25
Replace Lea Paloheimo with:
Lea Paloheimo Finland
Hanneke de Kort Netherlands
Sandra Weih Germany
Shinta Tominaga Japan
A S Mee United Kingdom
Michele Di Candia United Kingdom
Erin Ohmann United States
Tiffany L Bamford Australia
George Gershman United States
Jeffrey Moore relative to Lea Paloheimo Finland Lea Paloheimo's profile →
Citations per field
00.5×1.5×1.9×
Lea Paloheimo · 1×
Citations per year

Countries citing papers authored by Jeffrey Moore

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Moore more than expected).

Fields of papers citing papers by Jeffrey Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Moore. The network helps show where Jeffrey Moore may publish in the future.

Co-authorship network of co-authors of Jeffrey Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Moore. A scholar is included among the top collaborators of Jeffrey Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Moore. Jeffrey Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 1
2 37
3 19
4 27
5 6
6 91
7 133
8
Substance P is required for the pathogenesis of EMCV infection in mice.
33

About Jeffrey Moore

Jeffrey Moore is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Immunology, having authored 8 papers that have together received 347 indexed citations. Recurring topics across this work include Gallbladder and Bile Duct Disorders (4 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Coronary Artery Anomalies (2 papers). The work is most often cited by research in Surgery (287 citations), Pulmonary and Respiratory Medicine (202 citations) and Hepatology (17 citations). Jeffrey Moore has collaborated with scholars based in United States and Canada. Frequent co-authors include Kasper S. Wang, John C. Magee, Saul J. Karpen, Jorge A. Bezerra, Vicky L. Ng, Cara L. Mack, Ronald J. Sokol, Riccardo Superina, Alan W. Flake and Kishore Iyer. Their work appears in journals such as Nature Materials, Hepatology and Annals of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026